Papers
5
Total Citations
86
H-Index
4
About
Paolo Emiliozzi is a distinguished urologic surgeon and researcher whose work centers on refining surgical techniques and outcomes in prostate cancer care. His major contributions lie in optimizing robot-assisted laparoscopic radical prostatectomy (RALP), particularly through studies that challenge conventional postoperative protocols. Emiliozzi’s most cited work, a 2017 study on prostate-specific antigen density (34 citations), demonstrated its value as a predictor of tumor upstaging and upgrading, offering clinicians a practical tool for risk stratification. He has also advanced perioperative care by investigating early catheter removal—showing that removing the urinary catheter on postoperative day 2 is feasible and safe in high-volume centers, with subsequent studies (9 and 2 citations) reinforcing this as a potential new standard. Emiliozzi’s prospective analysis of operative time and blood loss (12 citations) revealed their impact on surgical margins and functional recovery, providing actionable insights for surgeons. Beyond technical innovation, he has engaged in critical discourse on surgical education, notably through a 2017 paper (29 citations) examining the educational value versus potential harms of live surgery. With a career dedicated to evidence-based improvements in urologic oncology, Emiliozzi’s work continues to shape clinical practice and patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2Live surgery: highly educational or harmful?29 citations · 2017
- 3
- 4
- 5